# Corrigendum: Immunoproteasome inhibition attenuates experimental psoriasis

**Authors:** Marta del Rio Oliva, Mark Mellett, Michael Basler

PMC · DOI: 10.3389/fimmu.2023.1335691 · Frontiers in Immunology · 2024-01-16

## Full-text entities

- **Genes:** IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}
- **Diseases:** psoriasis (MESH:D011565), inflammation (MESH:D007249)
- **Chemicals:** IMQ (MESH:D000077271), vaseline (MESH:D010577), DAPI (MESH:C007293), IMQ ONX 0914 (-), ONX 0914 (MESH:C542291)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10825588/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10825588/full.md

---
Source: https://tomesphere.com/paper/PMC10825588